Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
Title: Phase 1/2 Study of the Bispecific 4-1BB and PD-L1 Antibody INBRX-105 Alone and in Combination With Pembrolizumab in Select Solid Tumors
Lead Author: Jong Chul Park, MD
Abstract: 742
Location: San Diego Convention Center, San Diego, CA - Hall A
Trial-in-progress poster presentation on Saturday, November 4th, 2023 from 9 AM – 8:30 PM Pacific Standard Time
Title: Phase 1/2 Study of the Hexavalent OX40 Agonist INBRX-106 Alone and in Combination With Pembrolizumab in Select Solid Tumors
Lead Author: Rachel E. Sanborn, MD
Abstract: 748
Location: San Diego Convention Center in San Diego, CA - Hall A
Trial-in-progress poster presentation on Saturday, November 4th, 2023 from 9 AM – 8:30 PM Pacific Standard Time
